Laurence Rodriguez, Appointed CEO of GenSight Biologics in D

16.01.2024 - Regulatory News: The Board of Directors of GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (the 'Company'), a biopharma company focused on developing and commercializing innovative gene therapies for retinal ...

Related Keywords

France , Laurence Rodriguez , Gensight Biologics , Sanofi Genzyme , Bernard Gilly , , Chief Executive Officer , Rare Diseases , Rare Blood Disorders , Alain Sahel , Sight Biologic , Mitochondrial Targeting Sequence , Leber Hereditary Optic Neuropathy , Gensight Biologic , Gensight Biologics Stock ,